Skip to main content

Multiple Sclerosis News

Related terms: MS

Autoimmune Diseases Linked to Digestive System Cancers

FRIDAY, Aug. 15, 2025 – Autoimmune diseases are associated with certain digestive system cancers, according to a review published in the September issue of eClinicalMedicine. Julia Reizner, from the...

Broader Formulary Coverage Linked to Lower Odds of MS Relapse

FRIDAY, Aug. 8, 2025 – Broader formulary coverage is associated with lower odds of multiple sclerosis (MS) relapse among Medicare beneficiaries, according to a study published online Aug. 1 in JAMA...

Increase Seen in Physician Visits ~15 Years Before MS Onset

THURSDAY, Aug. 7, 2025 – Health care use is increased years before onset of multiple sclerosis (MS), according to a study published online Aug. 1 in JAMA Network Open. Marta Ruiz-Algueró, M.D., ...

When Insurers Restrict MS Drug Coverage, Relapses Rise

TUESDAY, Aug. 5, 2025 — Multiple sclerosis (MS) patients might have a higher risk of relapse if their health insurance is stingy with prescriptions, a new study reports. Patients with insurance plans ...

MS May Begin Years Earlier Than Thought

MONDAY, Aug. 4, 2025 — People with multiple sclerosis (MS) begin experiencing new health issues up to 15 years before the classic signs of the illness appear, Canadian research shows. “MS can be dif...

Women Less Likely to Get Certain MS Meds Than Men

THURSDAY, July 31, 2025 — Women are less likely than men to receive multiple sclerosis (MS) meds that could help them manage the disease and delay disability, a new report finds. It could be that s...

Women With MS Less Likely Than Men to Receive Disease-Modifying Therapies

THURSDAY, July 31, 2025 – Women with multiple sclerosis (MS) are less likely to receive disease-modifying therapies (DMTs) than men, according to a study published online July 30 in Neurology....

Blood Test Might Predict MS Relapse

TUESDAY, June 24, 2025 — A blood test might predict when multiple sclerosis patients are about to suffer a relapse in their symptoms, a new study says. Blood levels of a protein called neurofilament l...

Greater Epigenetic Age Seen in Patients With Pediatric-Onset MS

TUESDAY, June 17, 2025 – Individuals with pediatric-onset multiple sclerosis (POMS) have greater epigenetic age and age acceleration residual (AAR) compared with age-similar controls, according to a...

Children With MS Age Faster, Study Says

MONDAY, June 16, 2025 — Kids with multiple sclerosis (MS) age at an accelerated rate as the disease causes advanced wear and tear on their bodies, a new study says. This accelerated aging extends i...

Home-Based Exercise, Coaching Improves Fitness in Neuromuscular Diseases

WEDNESDAY, June 4, 2025 – Combined personalized home-based aerobic exercise and coaching improves physical fitness for people with neuromuscular diseases, according to a study published online June...

AI Can Help Track MS Progression

MONDAY, May 19, 2025 — Artificial intelligence (AI) can help detect when a person’s multiple sclerosis (MS) has reached an advanced state, a new study says. A newly developed AI correctly judged with ...

Neuromodulation Methods Show Comparable Outcomes for Neurogenic Bladder in Women With MS

WEDNESDAY, May 7, 2025 – For female patients with multiple sclerosis (MS), transcutaneous posterior tibial nerve stimulation (TPTNS) and repetitive transcranial magnetic stimulation (rTMS) are...

Experimental Drug Can Slow MS Disability

WEDNESDAY, April 9, 2025 – An experimental drug can help patients with advanced multiple sclerosis (MS) delay the progressive disability that comes with their disorder, a new clinical trial...

AAN: Tolebrutinib Slows Disability in Nonrelapsing Secondary Progressive MS

WEDNESDAY, April 9, 2025 – Tolebrutinib, a brain-penetrant and bioactive Bruton tyrosine kinase inhibitor that modulates persistent immune activation within the central nervous system, slows...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Related drug support groups

prednisone, methylprednisolone, Medrol, prednisolone, valacyclovir, dexamethasone, Tecfidera, Ocrevus, Gilenya, dimethyl fumarate, Aubagio